TAOK1

Across TCGA pan-cancer cohorts, TAOK1 mass-spec protein is linked to patient survival in 6 of 34 cancer types, making it a survival-associated TAOK1 data layer compared with 28 for mass-spec protein and 11 for mutation status.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where higher TAOK1 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated TAOK1 expression acts as an unfavorable survival marker.

CCRCC, LUAD, and GBM are the cancer types where TAOK1 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
CCRCC	OS	Median	III,IV	0.133	0.989	.013	27	view →
LUAD	OS	Median	II,III,IV	0.337	0.908	.002	22	view →
GBM	DFS	Median	All	0.253	0.487	.007	9	view →
LSCC	OS	Quartile	All	0.807	0.922	.042	3	view →
HNSC	DFS	Median	IV	0.328	0.889	.014	2	view →
PDAC	OS	Quartile	III,IV	0.265	0.526	.036	2	view →

Pink = unfavorable, green = favorable. Showing the 6 strongest of 6 lineages.

TAOK1–CCRCC (OS)

Open the CCRCC breakdown →